Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

News Conference News VEITH 2019

Uproar Continues Over UK NICE Guidelines Restricting EVAR for AAA

November 26, 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

News Conference News VIVA 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

November 07, 2019

EVAR Explants: Technical Challenges and Outcomes

Presentation TCT 2019

EVAR Explants: Technical Challenges and Outcomes

Presenter: Virendra Patel

September 27, 2019

New Developments in the Management of Acute Uncomplicated TBAD

Presentation TCT 2019

New Developments in the Management of Acute Uncomplicated TBAD

Presenter: Virendra Patel

September 27, 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

September 19, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

May 06, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

News Daily News

Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds

February 08, 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

News Conference News ISET 2019

Vici Venous Stent Shows Good Primary Patency, Few MAE by 12 Months: VIRTUS

February 08, 2019

VIRTUS: Trial Design adn Primary Endpoint Results

Presentation ISET 2019

VIRTUS: Trial Design adn Primary Endpoint Results

Presenter: Robert Lookstein

January 30, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.